GlassScriptPhysician profile
Renchell J A Andres
NPI 1386815199
$1,220.98
in general payments reported to CMS, 2019-2025
16 companies · $281 in 2025
The $281 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.31 · 2020: $86.62 · 2021: $125 · 2022: $256 · 2023: $85.50 · 2024: $327 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $246.88 | 2019-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $156.52 | 2022-2025 | Entyvio, Eohilia |
| Genzyme Corporation | $137.41 | 2022-2025 | |
| Abbvie INC. | $133.36 | 2020-2022 | |
| Boston Scientific Corporation | $129.95 | 2024 | Spaceoar Vue System - 10ml |
| Phathom Pharmaceuticals, INC. | $93.48 | 2024-2025 | Voquezna |
| La Jolla Pharmaceutical Company | $84.17 | 2025 | |
| Janssen Biotech, INC. | $39.93 | 2023 | Simponi, Simponi Aria, Remicade |
| Intercept Pharmaceuticals, INC. | $36.08 | 2022-2024 | |
| Lilly USA, LLC | $30.66 | 2025 | Omvoh |
| Braintree Laboratories, INC. | $30.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27.38 | 2024 | Dificid |
| Ethicon US, LLC | $22.81 | 2021 | |
| Redhill Biopharma INC. | $22.55 | 2022 | |
| Nestle Healthcare Nutrition INC. | $16.26 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renchell Andres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.